Association Between Haptoglobin Genotype and Brain Swelling

N/ATerminatedNCT02054117

University of Florida9 enrolled

Overview

Intracerebral hemorrhage is bleeding into the brain and is a major cause of stroke and other complications. Brain injury from intracerebral hemorrhage occurs in two phases. The early phase involves the mechanical compression of brain tissue by the expanding hematoma. In a later phase, brain swelling develops causing further compression that may lead to brain herniation and death. This study investigates the neuroprotective role of haptoglobin, in minimizing the development of brain swelling following intracerebral hemorrhage.

Intracerebral hemorrhage is bleeding into the brain parenchyma. It is a major cause of stroke, and is associated with significant morbidity and mortality. Brain injury from intracerebral hemorrhage occurs in two phases. The early phase involves the mechanical compression of brain tissue by the expanding hematoma. In a later phase, brain edema, especially perihematomal edema, develops causing further compression that may lead to brain herniation and death. Several factors are implicated in the development of brain edema, including inflammation resulting from the oxidative stress caused by iron-rich hemoglobin released from lysed erythrocytes in brain tissue. This study investigates the neuroprotective role of an acute phase reactant, haptoglobin, in minimizing the development of perihematomal edema following intracerebral hemorrhage. This protein protects brain tissue from hemoglobin degradation products by forming haptoglobin-hemoglobin complexes that are subsequently cleared by the spleen. Notably, different alleles of haptoglobin exist in humans, with varying affinities for hemoglobin. Investigating the association between the different alleles and the degree of perihematomal edema formation is the primary goal of this study. The investigators will also look at a marker of inflammation, matrix metalloproteinases, and analyze its level of expression in subjects with different alleles of haptoglobin.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Intracerebral Hemorrhage

Interventions

Intracerebral HemorrhageOTHER

Spontaneous intracranial or intraparenchymal hemorrhage that occurred in a supratentorial location.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 85 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Spontaneous intracranial or intraparenchymal hemorrhage * 18-85 years of age * Hemorrhage occurred in a supratentorial location Exclusion Criteria: * Inability to obtain consent within 3 days of hemorrhage onset * Known pregnancy * Therapeutic anticoagulation with Lovenox, Coumadin or Heparin * Prior history of therapeutic radiation to any area * Brain tumor * Hemorrhage related to trauma, aneurysm, arteriovenous malformation or other vascular malformation * Central nervous system infection * Subdural hematoma * Subarachnoid hemorrhage * Chronic immunosuppression, including steroids or chemotherapy agents * Infratentorial location * Unable to obtain MRI due to mental status or other contraindication (metal, pacemaker, etc.)

Locations (1)

University of Florida

Gainesville, Florida, United States

Outcomes

Primary Outcomes

Perihematomal Edema Volume

Perihematomal edema will be measured by averaging the edema area over multiple slices and subtracting the hemorrhage area from the total lesion area.

Time frame: Post-hemmorhage day 3

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.